Wednesday, April 23, 2014

Cipher names Thomas Wellner to board

Cipher names Thomas Wellner to board

March 25, 2014 by · Leave a Comment 

Tweet Cipher Pharmaceuticals (OTCBB:CPHMF; TSX:DND) has appointed Thomas Wellner to the board. Most recently, Mr. Wellner was co-CEO of LifeLabs, Canada’s largest laboratory services company, where he was responsible for leading the integration of CML HealthCare into LifeLabs’ organization. Prior to LifeLabs, he was president and CEO of CML HealthCare. “Tom has a strong background […]

Larry Andrews steps down as Cipher Pharma head

Larry Andrews steps down as Cipher Pharma head

March 14, 2014 by · Leave a Comment 

Tweet Larry Andrews will be stepping down from his position as president and CEO of Cipher Pharmaceuticals (OTCBB:CPHMF; TSX:DND). To ensure a smooth transition of responsibilities, Mr. Andrews will remain with the company for a period of time while the board undertakes a search process. He will then continue working with Cipher in a consulting […]

Cipher posts record Q4 and full-year 2013 results

Cipher posts record Q4 and full-year 2013 results

February 26, 2014 by · Leave a Comment 

Tweet Cipher Pharmaceuticals (OTCBB:CPHMF; TSX:DND) has reported fourth quarter profit of $17-million or 69 cents a share, compared with $1.5-million or 6 cents in the 2012 quarter. Revenue rose to $12.5-million from $2.9-million. “Strong performance from Absorica, including a sales milestone we achieved in the fourth quarter, helped drive significant revenue and earnings growth in […]

Cipher names Gerald McDole as chairman

Cipher names Gerald McDole as chairman

February 5, 2014 by · Leave a Comment 

Tweet Cipher Pharmaceuticals (OTCBB:CPHMF; TSX:DND) has appointed Gerald McDole as chairman, effective immediately, replacing William Garriock, who resigned on Dec. 31, 2013. Mr. McDole has been a member of the Cipher board since 2004. He retired as president and CEO of AstraZeneca Canada’s pharmaceutical operations at the end of 2003.

Cipher gets Absorica milestone payment

Cipher gets Absorica milestone payment

January 21, 2014 by · Leave a Comment 

Tweet Cipher Pharmaceuticals’ (OTCBB:CPHMF; TSX:DND) marketing partner for Absorica has reached a cumulative sales milestone in accordance with the parties’ commercial agreement, triggering a one-time $5-million payment to Cipher. The company said the revenue would be included in its fourth quarter 2013 financial results, which it plans to report in late February. Absorica is an […]

Cipher Pharma chairman to retire

Cipher Pharma chairman to retire

December 30, 2013 by · Leave a Comment 

Tweet William Garriock, chairman of Cipher Pharmaceuticals (OTCBB:CPHMF; TSX:DND), is retiring from active business and has resigned as chairman, effective tomorrow. “On behalf of the board, i would like to thank Bill for his service and contributions, and wish him well in retirement,” CEO Larry Andrews said in a statement.

Cipher Pharma Q3 profit jumps to $3.4-million

Cipher Pharma Q3 profit jumps to $3.4-million

October 30, 2013 by · Leave a Comment 

Tweet Third quarter net income for Cipher Pharmaceuticals (OTCBB:CPHMF; TSX:DND) rose to $3.4-million, or 14 cents a share, from $754,000, or 3 cents, in the year earlier quarter. Net revenue climbed to $5.6-million from $2.1-million. “Absorica performed well again in the third quarter, with market share increasing to 17.3% by September from 13.1% in June, […]

Cipher posts Q&A about Paragraph IV Certification

Cipher posts Q&A about Paragraph IV Certification

October 5, 2013 by · Leave a Comment 

Tweet Cipher Pharmaceuticals (OTCBB:CPHMF; TSX:DND), in response to questions from shareholders about a Paragraph IV Certification received by its U.S. marketing partner, Ranbaxy Laboratories, has posted on its website some of the most frequently asked questions and Cipher’s response. The Q&A can be accessed here.

Cipher added to S&P/TSX SmallCap Index

Cipher added to S&P/TSX SmallCap Index

September 16, 2013 by · Leave a Comment 

Tweet As a result of its annual review, S&P Dow Jones Canadian Index Services is making changes to the S&P/TSX SmallCap Index at the close of trading this Friday, with Cipher Pharmaceuticals (TSX:DND; OTCBB:CPHMF) replacing CML Healthcare Inc.  

Cipher posts big jump in Q2 revenue and profits

Cipher posts big jump in Q2 revenue and profits

July 31, 2013 by · Leave a Comment 

Tweet Cipher Pharmaceuticals (OTCBB:CPHMF; TSX:DND) has reported net income of $3.1-million or 13 cents a share on revenue of $5.5-million for the second quarter, compared with $200,000 or 1 cent on revenue of $1.6-million a year earlier. “The continued strong growth of Absorica drove significant gains in our revenue, earnings and cash for the second […]

Next Page »

Google+